Scientist II/III (master or Bachelor degree level)
with strong interpersonal communication skills to join the talented Cancer Immunology & Immune Modulation (CI & IM) Research Group at Boehringer Ingelheim’s US research facility in Ridgefield, CT. The successful candidate will work within the CI&IM in vivo pharmacology group to advance both exploratory and drug candidate discovery programs and provide target discovery/validation, in-vivo efficacy, mechanism of action (MOA) and pharmacodynamic data essential to drive projects into clinical development. The ideal candidate will collaborate with other members of in vivo teams and with ...
Source: mitbbs.com